It is well known that MAC, the minimum alveolar concentration required to prevent movement in response to surgical incision in 50 % of patients, decreases with age. Regression analysis showed that data for humans derived from a comprehensive literature survey were consistent, for age 9 1 yr, with log 10 MAC decreasing with increasing age at the same rate for all inhaled anaesthetics; approximately equivalent to 6 % change per decade of age. With some slight reservation on differences between data from different institutions, the present data for humans are consistent (for age 9 1 yr) with the equation MAC has been defined as "the minimum alveolar concentration of anaesthetic at 1 atmosphere that produces immobility in 50 per cent of those patients or animals exposed to a noxious stimulus" [1] . There is the rider [1] that the alveolar concentration must have been held constant for long enough for the brain to come into equilibrium with the alveolar concentration. In humans, the stimulus is normally surgical incision.
MAC has been defined as "the minimum alveolar concentration of anaesthetic at 1 atmosphere that produces immobility in 50 per cent of those patients or animals exposed to a noxious stimulus" [1] . There is the rider [1] that the alveolar concentration must have been held constant for long enough for the brain to come into equilibrium with the alveolar concentration. In humans, the stimulus is normally surgical incision.
It is well known that MAC decreases with age and some authors [2] [3] [4] [5] have drawn attention to similarities between agents in the trend of MAC with age. A need to express measured end-tidal concentrations of halothane, enflurane and isoflurane in terms of MAC units in patients of different ages [6] provided the stimulus to try to derive, from published data, a general equation to represent the dependence of MAC on age. Thus, in the terms of Andersen [7] , this is an "inductive, hypothesis-generating" study, not a hypothesis-testing one.
Methods

SELECTION OF DATA FOR ANALYSIS
The selection was restricted to peer-reviewed investigations which used inhalation induction and, with one exception, no premedication or only atropine, and which reported, for each group studied, the number of patients, mean age and the value of MAC derived. Data for alternative forms of MAC, such as MAC for tracheal intubation [8] , and MAC based on "grimace or movement" [9] rather than only on movement, were excluded: although the dependence of the grimace variant of MAC on age seems very similar to that of conventional MAC, MAC for tracheal intubation under sevoflurane appears to increase with age [10, 11] . Similarly, values for MAC derived from movement in response to electrical stimulation were excluded because there is some evidence [12] that they may not be consistent with values based on response to surgical incision.
Literature searches in the Embase and Medline databases, together with examination of the citations in the resulting papers, yielded a total of 30 articles [2] [3] [4] [5] containing data that met the selection criteria. These included nine articles from which indirect estimates of MAC for nitrous oxide were derived (appendix). Direct estimate in volunteers at hyperbaric pressures [36] was not used because this was based on the response to electrical stimulation.
STRATEGY FOR COMBINING DATA FROM DIFFERENT
STUDIES
Only one article [12] , from Berne at 500 m above sea level, reported a correction (96 % of MAC) for altitude, as the definition of MAC is in terms of the concentration of anaesthetic at 1 atmosphere [1] . For the present study, corrections were also applied to results from studies conducted at more than 100 m above sea level: Iowa 92.5 %; Durham, North Carolina (Duke University), 91.5 %; Milan 91.5 %.
All estimates of MAC were included in a multiple linear regression analysis. Because of the wide range of MAC values between different anaesthetics (more than 100 to one), log 10 MAC was used as the dependent variable. Individual estimates of MAC were generally weighted in proportion to the number of patients included in each group (appendix). Inspection of the data suggested that values of MAC for children, especially those less than 1 yr of age, might be inconsistent with the trend for adult data; therefore analyses were performed for all ages, age 91 yr and age 918 yr.
For each of these three analyses, three versions of the regression were tried, on the basis of three different assumptions.
(1) All estimates of MAC for a given anaesthetic are equally valid (apart from the weighting). For this version, a set of parallel lines was fitted, one for each anaesthetic. This used all of the data.
(2) There may be differences between institutions because of slightly different techniques or because different populations were sampled. This version required a separate parallel line for each institution within each anaesthetic. This is equivalent to basing the slope only on data from those institutions that have studied more than one age group.
(3) There may be differences even between studies within the same institution. This version required a separate parallel line for each study. It involved basing the slope only on data which included more than one age group in a single study.
Within each of these three versions, evidence of curvature of the regression of log MAC on age was sought by adding (age) 2 and (age) 3 to the predictor terms, and evidence of differences between anaesthetics in the dependence of log MAC on age by allowing a separate slope for each agent.
Each elaboration or restriction of the model was tested for improvement of fit and adopted only if it yielded P : 0.05. This is a regression equivalent of a procedure [37] for testing for consistency of groups in a meta-analysis of means.
Further inspection of the data showed that only one study (for halothane [14] ) included data for children in addition to adults, and that this study would have a dominant effect on the results of the one-line-per-study analyses. However, there were two instances where one anaesthetic (sevoflurane) was the subject of two studies from the same institution, with one or more authors in common, published in the same or consecutive years, with one dealing with children and the other with adults. Therefore, for the purpose of the analyses, each of these pairs of studies ( [10, 11] and [5, 27] ) was treated as a single study.
The statistical package used was GLIM 4, [38, 39] 
Results
The input data derived from the literature survey are listed in table 1.
Regression analyses showed that, whichever age range was included (all, 91 yr, 918 yr), it was essential to allow a separate line for each institution (P always :0.0006) but not for each study (P always 90.06). With one line per institution (or one per study) there was a strong improvement in fit by restricting age to 91 yr (P : 0.0001) but little further improvement on restricting to 918 yr (P 9 0.09). There was no significant curvature in any model, except for one line per institution using all ages (P : 0.03), nor any significant difference in slope between anaesthetics. Thus the optimum model was that with the data restricted to age 9 1 yr, and with a separate parallel straight line for each institution for each anaesthetic. This gave a slope of log 10 MAC on age of:
with 95 % confidence limits (CL) of -0.0030 and 90.0024, that is <12 %. This corresponds to a change in MAC of approximately 6 % per decade of age or, more precisely, a 22 % decrease from 40 to 80 yr of age and a 27 % increase from 40 to 1 yr of age.
To avoid explicitly stating a notional, but misleading, MAC at age 0, it is preferable to express the results relative to MAC at some intermediate age.
Forty years has been chosen as a convenient midpoint. Thus, the overall results can best be summarized by the equation:
where x : difference in age (in years) from 40 yr, b : slope of log 10 MAC on age (equation (1) Conformity of the original data to the fitted regression lines is shown in figure 1 . The main part of the graph shows measured values and fitted lines for age 91 yr; the left of the graph shows extrapolation to zero age (broken lines), and measured values for age :1 yr, on a 10-times expanded age scale (hence the flatter slope of the broken lines). To avoid cluttering the graph, data for five agents have been omitted: each of those lines would simply go through the one measured value.
Discussion
The available data are consistent with the hypothesis that all inhaled anaesthetics have a common slope of log10 MAC on age, for age 91 yr, but that there may be differences between institutions in MAC for an anaesthetic, for any particular age. A theory of why a common slope is not surprising is given in the appendix.
A common slope for log MAC on age is consistent with the findings that the change in linear MAC with age is the same for several agents only if MAC for each agent, at any age, is expressed as a percentage of MAC for that agent at some standard age [2, 3] , or if some equivalent scaling manoeuvre is used [4, 5] .
These findings are not contradicted by the observation [3] that the slope of MAC on age for a volatile anaesthetic, when combined with a fixed concentration of nitrous oxide, is steeper than that for the volatile alone. This arises because the fixed concentration of nitrous oxide represents a larger fraction of MAC at the greater age; therefore a smaller fraction of MAC needs to be supplied by the volatile agent.
The difference in fitted MAC between institutions might be attributable to the sampling of different populations. There is some evidence in table 2 of MAC values from North America being greater than those from Europe (isoflurane and enflurane) or Japan (sevoflurane), but there are comparable or wider differences between institutions within North America (halothane, isoflurane, desflurane and nitrous oxide) or Japan (sevoflurane). Also, part of the difference in the case of isoflurane could be attributed to the use of temazepam 20 mg orally as premedication in one of the European studies [22] . Therefore, the differences may all be attributable to slight variations in technique, including differences in the absolute calibration of the gas analysers used. It is on this basis that a "global" value is given for each of these anaesthetics in table 2 and global fitted lines are plotted in figure 1 .
It is the residual SD of the (age 91 yr) data points around these global lines (corresponding to 95 % of the points lying within approximately <20 % of the predicted values) which has been used in calculating the confidence limits in table 2. Apart from a small addition arising from uncertainty over the slope of the dependence on age, the confidence limits at age 40 yr, as a percentage of MAC, are equal to approximately 20 √(17/w), where w : total weight for the anaesthetic (usually the number of patients studied) and 17 is the average weight per MAC value in table 1 for age 91 yr. For each anaesthetic which has been the subject of only one study, with 15 to 28 patients, the confidence limits are considerably wider than any derivable from the study itself. This is because the confidence limits in table 2 allow for the general variability between studies and between institutions, which variability is absent from the results of any one study.
The left-hand part of figure 1 shows that, for ages less than 1 yr, the proportion of measured values lying within -18 %, +23 % of the extrapolations of the regression lines is not 95 % but only 70 % (10 of 14). Until recently it was possible to argue [34] that there was a consistent trend for young children, with MAC reaching a peak at around 6 months of age, but recent data on sevoflurane in this age range [31] appear to contradict this. The poor agreement with extrapolations of the global lines could be reduced by postulating a steepening of the lines in the early years of life. Certainly, the mainly non-significant curvatures found in the regression analyses were mostly in this direction. The remainder of the scatter could then be attributed to most of these MAC values being based on only 12 patients each, instead of the mean of 17 for age 91 yr. However, it is clear that further studies in this age range, with larger numbers of patients, are needed to resolve the discrepancies.
As MAC is defined in terms of anaesthetic concentration at 1 atmosphere, corrections should be applied, not only for the systematic effect of altitude (as was done in this analysis), but also for day-to-day variations in barometric pressure. This could not be done because none of the studies reported barometric pressure. The range of barometric pressure amounts to about <5 % (about 95-105 kPa at sea level), but each study would be spread over at least several days so that mean pressures for different studies would generally vary less than this. Therefore, this can account for only a small fraction of the scatter in figure 1 . However, it is probably unwise to draw conclusions from differences of less than 5 % between studies.
A further source of uncertainty is the difference between end-tidal and arterial partial pressure because it is the latter with which the site of action of the anaesthetic will equilibrate. This difference can be expected to vary with the degree of ventilationperfusion mismatch in the lungs and so account for some of the scatter in figure 1 . However, even if all studies were carried out in terms of arterial partial pressure, this would not be very helpful clinically because such measurements are not generally available.
A few studies (* in table 1) reported full data for each individual patient: end-tidal concentration, age and whether or not the patient moved. With such data it is possible, in principle, to obtain an estimate of MAC, and also its dependence on age, from a single study. This can be done using logistic regression or probit analysis to predict "not move" from both log concentration and age. When this was tried, it was found that most individual studies failed to show a significant dependence on age because each covered only a small range of ages. However, combining the results from the nine groups of patients receiving only a volatile anaesthetic, and using a separate intercept for each institution, gave a slope of -0.00288 log 10 MAC yr 91 compared with the present -0.00269, and confidence limits of <27 % (based on 182 patients, a weight of 182 as defined in the appendix) compared with the present <12 % (around one line per institution and based on a weight of 993).
The ratio of these two percentage confidence limits (2.25) is nearly the same as the ratio of the square roots of the two weights (2.34), and therefore overall there is no particular advantage in one technique over the other. However, the logistic or probit technique would have an advantage within a single large study: if it is desired to determine MAC for a range of ages, the current procedure is to study say 20 patients in each of three or four age groups, determine MAC for each group, and perhaps fit a line to the three or four results leading to a slope with a standard error which would have only one or two degrees of freedom. Instead, it would be better to handle all the results in one analysis to predict the probability of movement from log concentration and age so that the standard error of the slope on age would have almost as many degrees of freedom as the number of patients studied.
Stewart and Parmar [40] have demonstrated the advantages of "meta-analysis of individual-patient data" (MAP) compared with "meta-analysis of the literature" (MAL) in the context of survival studies. The main analysis in this article, using just MAC and mean age from each study group, is an example of MAL; logistic analysis of those studies which gave full data on individual patients is an example of MAP. Therefore, the fact that the two "MAP/MAL" ratios (ratio of percentage confidence limits and ratio of the square roots of the weights) were so similar suggests that MAP has no advantage over MAL in the present context, unless additional information was obtained from the original authors, as Stewart and Parmar did.
In conclusion, it is suggested that the parallel lines defined by equations (1) and (2), and the numerical values in table 2, represent the current best estimates of MAC, and its dependence on age, for the 12 inhaled anaesthetics listed, and for age 91 yr. However, the present data allowed only limited testing of differences in slope between anaesthetics or in intercept between institutions or studies so it may be that, as more data are accumulated, the true picture will prove to be more complex. In the meantime, the present global regression lines provide a consistent basis for expressing measured concentrations of these anaesthetics as fractions or multiples of MAC at any age 91 yr. The lines are typified by the values for isoflurane: MAC : 1.49 % at age 1 yr, 1.17 % at 40 yr and 0.91 % at 80 yr.
Appendix
DERIVATION OF MAC FOR NITROUS OXIDE
Several articles give values for MAC for a volatile anaesthetic, and for the same volatile agent when mixed with a fixed concentration of nitrous oxide. It now seems clear [41] , despite earlier doubts [42, 43] , that the current inhaled anaesthetics are additive in their effects. Therefore, it is possible to estimate MAC for nitrous oxide from:
fixed end-tidal concentration of nitrous oxide, and FEЈvol1 and FEЈvol2 : end-tidal concentrations of volatile agent required to prevent movement in 50 % of patients, with and without nitrous oxide, respectively. This has been done here for six studies [3, 4, 28, [31] [32] [33] . In three further studies where a volatile anaesthetic was combined with two or more concentrations of nitrous oxide [19, 24, 26] , MAC values for both agents can be obtained by extrapolation to zero volatile concentration for nitrous oxide and, where necessary [26] , to zero nitrous oxide concentration for the volatile agent.
In studies where only the inspired concentration of nitrous oxide has been reported, the end-tidal concentration has been taken to be 0.97 of the inspired concentration to allow for a theoretical [44] 3 % incomplete equilibration of alveolar with 70 % inspired nitrous oxide at 20-30 min after the start of administration. Where only the carrier gas concentration has been reported, the inspired concentration has first been estimated by multiplying by (1 -F v ) where F v : fractional concentration of the volatile agent in the nitrous oxide-volatile mixture.
WEIGHTING OF STUDIES
The best method of combining a number of estimates is to weight each in proportion to the reciprocal of its variance: this leads to a minimum-variance combined estimate [45] . Standard errors, where they are reported in the literature, vary widely and this is likely to be, at least in part, because of the relatively small numbers of patients in any one group and probably to different methods of estimating SE. Therefore, it is assumed here that the variability between patients is inherently a constant, and the same for all inhaled anaesthetics. On this basis, the appropriate weighting of the mean age data can be achieved by making the weight of each estimate of MAC proportional to the number of patients on which it is based.
In the case of nitrous oxide, most estimates of MAC are derived from the difference between MAC values for a volatile in two groups of patients, with and without nitrous oxide (or with two different concentrations of nitrous oxide). The variance of a difference is the sum of the two variances, so the appropriate weighting is n/2, where n : number of patients in each group, or (n 1
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)
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, when the numbers n1 and n2 in the two groups are unequal. For each of the two studies [19, 24] which obtained MAC for nitrous oxide in children by extrapolation to zero concentration of the volatile anaesthetic, three differences were involved. Therefore, the variances of each of the resulting estimates of MAC for nitrous oxide can be thought of as each arising from the mean of three differences; therefore the estimates were assigned weights of 3n/2 (where n : number of patients in each group) as a tolerable approximation for the purpose of the present analyses.
THEORY
It is well known that MAC for inhaled anaesthetics is closely, negatively, correlated with the oil/gas partition coefficient [46] . Using the present fitted values of MAC (in percentages) at age 40 yr, and the values of the ratio l from Halsey [47] , leads to a mean value for MAC of 130 with an SD of 28-a coefficient of variation of 20 %. Compared with the range of MAC values between different anaesthetics (a ratio of 650 between the largest and smallest) this is small. As many investigators have noted [46] , this suggests that the site of action of inhaled anaesthetics is lipid-like.
Assume that for any one of the 12 anaesthetics studied here, the concentration Cs at the site of action (for no movement in response to the surgical incision in 50 % of patients) can be represented by s s MAC C = λ × where s : site/gas partition coefficient for that anaesthetic.
Assume also that Cs is the same for all 12 anaesthetics (at any given age) and that, for each anaesthetic, s is independent of age. Then, for any two inhaled anaesthetics i, j, at any two ages a, b, that is the decrease in logMAC from age a to age b is the same for anaesthetics i and j, and therefore for all 12 anaesthetics. Thus the current finding of a common slope of log MAC on age for all 12 anaesthetics is to be expected if the concentration required at the site of action is the same for all anaesthetics and if each s is independent of age. The mathematics can readily be extended to include the case of s being dependent on age but with log s having the same slope on age for all 12 anaesthetics.
The above argument is a long way from proving that the variation of MAC with age should be the same for all anaesthetics, but it does show that the present result is not surprising.
